BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 1, 2026
Home
»
Authors
» Jennifer Boggs
Jennifer Boggs
Articles
ARTICLES
Alexza Prices IPO At $44M To Finance Clinical Work
March 9, 2006
By
Jennifer Boggs
Neuromed's $25M To Fuel Calcium Channel Research
March 9, 2006
By
Jennifer Boggs
Neuromed's $25M To Fuel Calcium Channel Research
March 9, 2006
By
Jennifer Boggs
Alexza Prices IPO At $44M To Finance Clinical Work
March 9, 2006
By
Jennifer Boggs
BiPar Begins Clinical Work With Lead Drug In Portfolio
March 8, 2006
By
Jennifer Boggs
BiPar Begins Clinical Work With Lead Drug In Portfolio
March 8, 2006
By
Jennifer Boggs
Heading To Clinic, Nereus Adds $18.3M To Series D
March 7, 2006
By
Jennifer Boggs
Heading To Clinic, Nereus Adds $18.3M To Series D
March 7, 2006
By
Jennifer Boggs
ARCA Gets $15M Series A To Support Bucindolol NDA
March 6, 2006
By
Jennifer Boggs
ARCA Gets $15M Series A To Support Bucindolol NDA
March 6, 2006
By
Jennifer Boggs
View All Articles by Jennifer Boggs
